The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Genetic analysis of von Hippel-Lindau disease
Open accessAbstract
Mutations in the von Hippel-Lindau (VHL) gene are responsible for VHL disease, congenital polycythemia, and are found in many sporadic tumor types as well. Reports of VHL mutations are dispersed throughout original articles and databases that have not been recently updated. We compiled a comprehensive mutation table of 1,548 germline and somatic VHL mutations, derived from this protein of only 213 amino acids. We describe detailed phenotype and gene mutation information for 945 VHL families, including 30 previously unpublished kindreds from The Netherlands (six novel mutations). These data represent the most extensive catalog of germline VHL mutations to date. We also review VHL disease, known and theorized pathogenesis of common VHL manifestations, and genotype-phenotype correlations. Analysis of all VHL families, excluding germline mutations resulting in congenital polycythemias, describes the spectrum of mutation types: 52% missense, 13% frameshift, 11% nonsense, 6% in-frame deletions/insertions, 11% large/complete deletions, and 7% splice mutations. This easy-to-use compilation of VHL mutations is intended to facilitate research and function as a necessary adjunct for physicians when providing patient information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“…then delivers HIF-a to an E3-ubiquitin ligase complex through binding of Elongins B and C, and subsequent proteasomal degradation [Hon et al., 2002; Ivan et al., 2001; Jaakkola et al., 2001; Jiang et al., 2003; Maxwell et al., 1999; Min et al., 2002; Vengellur et al., 2003; Wykoff et al., 2000; Yu…”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Human Gene Mutation Database (HGMD®): 2003 update: HGMD 2003 UPDATE
Stenson, P. D., Ball, E. V., Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S. T., Abeysinghe, S., Krawczak, M., & Cooper, D. N. (2003) · Human Mutation · doi:10.1002/humu.10212 · Cited by 1,829
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13643-4 · Cited by 1,600
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135 · cited 1×
“…that are upregulated in the absence of pVHL (or presence of HIF) promote the adaptive response to hypoxia and can be classified into oxygen transport genes (e.g., EPO), promoters of angiogenesis (e.g., VEGF) and anaerobic energy metabolism genes (e.g., GLUT1 glucose transport gene) [Wenger, 2002].”
BackgroundAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Principles of Tumor Suppression
Sherr, C. J. (2004) · Cell · doi:10.1016/s0092-8674(03)01075-4 · Cited by 1,034
The Epidemiology of Renal Cell Carcinoma
Ljungberg, B., Campbell, S. C., Cho, H. Y., Jacqmin, D., Lee, J. E., Weikert, S., & Kiemeney, L. A. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.049 · Cited by 999
Role of VHL Gene Mutation in Human Cancer
Kim, W. Y., & Kaelin, W. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.061 · Cited by 943
Clinical Features and Natural History of von Hippel-Lindau Disease
MAHER, E. R., YATES, J. R. W., HARRIES, R., BENJAMIN, C., HARRIS, R., MOORE, A. T., & FERGUSON-SMITH, M. A. (1990) · QJM · doi:10.1093/qjmed/77.2.1151 · Cited by 937
Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., & Senger, D. R. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.2.211 · Cited by 898
Molecular basis of the VHL hereditary cancer syndrome
Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
Yu, F., White, S. B., Zhao, Q., & Lee, F. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181341498 · Cited by 796
Mutagenic deamination of cytosine residues in DNA
Duncan, B. K., & Miller, J. H. (1980) · Nature · doi:10.1038/287560a0 · Cited by 792
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.1073440 · Cited by 765
Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751
Tumour suppression by the human von Hippel-Lindau gene product
Iliopoulos, O., Kibel, A., Gray, S., & Kaelin, W. G. (1995) · Nature Medicine · doi:10.1038/nm0895-822 · Cited by 703
Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
Kibel, A., Iliopoulos, O., DeCaprio, J. A., & Kaelin, W. G. (1995) · Science · doi:10.1126/science.7660130 · Cited by 671
Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation
Cohen, A. J., Li, F. P., Berg, S., Marchetto, D. J., Tsai, S., Jacobs, S. C., & Brown, R. S. (1979) · New England Journal of Medicine · doi:10.1056/nejm197909133011107 · Cited by 645
Von Hippel-Lindau disease: a genetic study.
Maher, E. R., Iselius, L., Yates, J. R., Littler, M., Benjamin, C., Harris, R., Sampson, J., Williams, A., Ferguson-Smith, M. A., & Morton, N. (1991) · Journal of Medical Genetics · doi:10.1136/jmg.28.7.443 · Cited by 595
Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
Nickerson, M. L., Jaeger, E., Shi, Y., Durocher, J. A., Mahurkar, S., Zaridze, D., Matveev, V., Janout, V., Kollarova, H., Bencko, V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4921 · Cited by 588
Preoperative Management of the Pheochromocytoma Patient
Pacak, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1720 · Cited by 576
Inhibition of Transcription Elongation by the VHL Tumor Suppressor Protein
Duan, D. R., Pause, A., Burgess, W. H., Aso, T., Chen, D. Y. T., Garrett, K. P., Conaway, R. C., Conaway, J. W., Linehan, W. M., & Klausner, R. D. (1995) · Science · doi:10.1126/science.7660122 · Cited by 568
Chen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., et al. (1995) · Human Mutation · doi:10.1002/humu.1380050109 · Cited by 556
von Hippel-Lindau disease: genetic, clinical, and imaging features.
Choyke, P. L., Glenn, G. M., Walther, M. M., Patronas, N. J., Linehan, W. M., & Zbar, B. (1995) · Radiology · doi:10.1148/radiology.194.3.7862955 · Cited by 550
Maher, E. R., & Kaelin, W. G. (1997) · Medicine · doi:10.1097/00005792-199711000-00001 · Cited by 528
Lee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M. S., Sajan, M. P., Farese, R. V., Freeman, R. S., Carter, B. D., Kaelin, W. G., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.015 · Cited by 527
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
Ang, S. O., Chen, H., Hirota, K., Gordeuk, V. R., Jelinek, J., Guan, Y., Liu, E., Sergueeva, A. I., Miasnikova, G. Y., Mole, D., et al. (2002) · Nature Genetics · doi:10.1038/ng1019 · Cited by 510
Zbar, B., Kishida, T., Chen, F., Schmidt, L., Maher, E. R., Richards, F. M., Crossey, P. A., Webster, A. R., Affara, N. A., Ferguson-Smith, M. A., et al. (1996) · Human Mutation · doi:10.1002/(sici)1098-1004(1996)8:4<348::aid-humu8>3.0.co;2-3 · Cited by 506
HIF activation identifies early lesions in VHL kidneys
Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00071-5 · Cited by 483
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
Stolle, C., Glenn, G., Zbar, B., Humphrey, J. S., Choyke, P., Walther, M., Pack, S., Hurley, K., Andrey, C., Klausner, R., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:6<417::aid-humu8>3.0.co;2-k · Cited by 479
Ohh, M., Yauch, R. L., Lonergan, K. M., Whaley, J. M., Stemmer-Rachamimov, A. O., Louis, D. N., Gavin, B. J., Kley, N., Kaelin, W. G., & Iliopoulos, O. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80096-9 · Cited by 477
Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., & Zbar, B. (1994) · PubMed · Cited by 471
Wanebo, J. E., Lonser, R. R., Glenn, G. M., & Oldfield, E. H. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.1.0082 · Cited by 467
Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease
Neumann, H., Berger, D. P., Sigmund, G., Blum, U., Schmidt, D., Parmer, R. J., Volk, B., & Kirste, G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292103 · Cited by 465
A large-scale prospective cohort study on diet and cancer in the Netherlands
van den Brandt, P. A., Goldbohm, R. A., Van 'T Veer, P., Volovics, A., Hermus, R. J. J., & Sturmans, F. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90009-e · Cited by 459
A.Crossey, P., M.Richards, F., Foster, K., reen, J. S., Prowse, A., Latlf, F., Lerman, M. I., Zbar, B., Atfara, N. A., Ferguson-Smith, M. A., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.8.1303 · Cited by 382
Hoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382
Lonergan, K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R. C., Conaway, J. W., & Kaelin, W. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.732 · Cited by 381
Clifford, S. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1029 · Cited by 373
Foster, K., Prowse, A., van den Berg, A., Fleming, S., Hulsbeek, M. M. F., Crossey, P. A., Richards, F. M., Cairns, P., Affara, N. A., Ferguson-Smith, M. A., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2169 · Cited by 373
Von Hippel-Lindau Disease Affecting 43 Members of a Single Kindred
LAMIELL, J. M., SALAZAR, F. G., & HSIA, Y. E. (1989) · Medicine · doi:10.1097/00005792-198901000-00001 · Cited by 361
高橋, 敦. (1994) · Medical Entomology and Zoology · doi:10.11501/3101325 · Cited by 352
Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus
Neumann, H. P. H., & Wiestler, O. D. (1991) · The Lancet · doi:10.1016/0140-6736(91)91705-y · Cited by 340
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL
Hergovich, A., Lisztwan, J., Barry, R., Ballschmieter, P., & Krek, W. (2003) · Nature Cell Biology · doi:10.1038/ncb899 · Cited by 339
Kaelin, W. G. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092049 · Cited by 336
Wizigmann-Voos, S., Breier, G., Risau, W., & Plate, K. H. (1995) · PubMed · Cited by 326
The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
Kaelin, W. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-sup-040025 · Cited by 318
Takahashi, A., Sasaki, H., Kim, S. J., Tobisu, K.-I., Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T., & Terada, M. (1994) · PubMed · Cited by 275
Banks, R. E., Tirukonda, P., Taylor, C., Hornigold, N., Astuti, D., Cohen, D., Maher, E. R., Stanley, A. J., Harnden, P., Joyce, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3074 · Cited by 275
Gordeuk, V. R., Sergueeva, A. I., Miasnikova, G. Y., Okhotin, D., Voloshin, Y., Choyke, P. L., Butman, J. A., Jedlickova, K., Prchal, J. T., & Polyakova, L. A. (2004) · Blood · doi:10.1182/blood-2003-07-2535 · Cited by 273
Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations
Wagner, K. R., Hamed, S., Hadley, D. W., Gropman, A. L., Burstein, A. H., Escolar, D. M., Hoffman, E. P., & Fischbeck, K. H. (2001) · Annals of Neurology · doi:10.1002/ana.1023 · Cited by 272
Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204012 · Cited by 266
Multiple Neuroendocrine Tumors of the Pancreas in von Hippel-Lindau Disease Patients
Lubensky, I. A., Pack, S., Ault, D., Vortmeyer, A. O., Libutti, S. K., Choyke, P. L., Walther, M. M., Linehan, W. M., & Zhuang, Z. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65563-0 · Cited by 260
Du, M., Liu, X., Welch, E. M., Hirawat, S., Peltz, S. W., & Bedwell, D. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711795105 · Cited by 256
Genotype-phenotype correlations in von Hippel-Lindau disease
Ong, K. R., Woodward, E. R., Killick, P., Lim, C., Macdonald, F., & Maher, E. R. (2007) · Human Mutation · doi:10.1002/humu.20385 · Cited by 250
WALTHER, M. M., CHOYKE, P. L., GLENN, G., LYNE, J. C., RAYFORD, W., VENZON, D., & LINEHAN, W. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68930-6 · Cited by 249
Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease
Manski, T. J. (1997) · JAMA · doi:10.1001/jama.277.18.1461 · Cited by 239
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
Young, A. P., Schlisio, S., Minamishima, Y. A., Zhang, Q., Li, L., Grisanzio, C., Signoretti, S., & Kaelin, W. G. (2008) · Nature Cell Biology · doi:10.1038/ncb1699 · Cited by 239
Formation of the VHL–Elongin BC Tumor Suppressor Complex Is Mediated by the Chaperonin TRiC
Feldman, D. E., Thulasiraman, V., Ferreyra, R. G., & Frydman, J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80233-6 · Cited by 238
pVHL and GSK3β are components of a primary cilium-maintenance signalling network
Thoma, C. R., Frew, I. J., Hoerner, C. R., Montani, M., Moch, H., & Krek, W. (2007) · Nature Cell Biology · doi:10.1038/ncb1579 · Cited by 238
p53 Stabilization and Transactivation by a von Hippel-Lindau Protein
Roe, J.-S., Kim, H., Lee, S.-M., Kim, S.-T., Cho, E.-J., & Youn, H.-D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.006 · Cited by 237
Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings.
Hough, D. M., Stephens, D. H., Johnson, C. D., & Binkovitz, L. A. (1994) · American Journal of Roentgenology · doi:10.2214/ajr.162.5.8165988 · Cited by 237
Whaley, J. M., Naglich, J. G., Gelbert, L. M., Hsia, Y. E., Lamiell, J. M., Green, J. S., Collins, D. L., Neumann, H. P. H., Laidlaw, J., & Li, F. P. (1994) · PubMed Central · Cited by 232
Schoenfeld, A., Davidowitz, E. J., & Burk, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8817 · Cited by 230
Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
Maher, E. R., Webster, A. R., Richards, F. M., Green, J. S., Crossey, P. A., Payne, S. J., & Moore, A. T. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.4.328 · Cited by 229
Lehrman, M. A., Russell, D. W., Goldstein, J. L., & Brown, M. S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61510-8 · Cited by 225
Schraml, P., Struckmann, K., Hatz, F., Sonnet, S., Kully, C., Gasser, T., Sauter, G., Mihatsch, M. J., & Moch, H. (2002) · The Journal of Pathology · doi:10.1002/path.1034 · Cited by 220
Haemangioblastoma of the central nervous system in von Hippel–Lindau disease
Richard, Campello, Taillandier, Parker, & Resche (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00337.x · Cited by 220
A Second Look: “The Agenda for ‘Social Science History’”
Beach, W. W. (1980) · Social Science History · doi:10.1017/s0145553200018976 · Cited by 220
Surgical management of brainstem hemangioblastomas in patients with von Hippel—Lindau disease
Weil, R. J., Lonser, R. R., Devroom, H. L., Wanebo, J. E., & Oldfield, E. H. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.1.0095 · Cited by 220
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Prowse, A. H., Webster, A. R., Richards, F. M., Richard, S., Olschwang, S., Resche, F., Affara, N. A., & Maher, E. R. (1997) · Europe PMC (PubMed Central) · Cited by 215
Pancreatic lesions in the von Hippel-Lindau syndrome
Neumann, H. P. H., Dinkel, E., Brambs, H., Wimmer, B., Friedburg, H., Volk, B., Sigmund, G., Riegler, P., Haag, K., Schollmeyer, P., et al. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90026-h · Cited by 214
Kanno, H., Kondo, K., Ito, S., Yamamoto, I., Fujii, S., Torigoe, S., Sakai, N., Hosaka, M., Shuin, T., & Yao, M. (1994) · PubMed · Cited by 208
Nudelman, I., Rebibo-Sabbah, A., Cherniavsky, M., Belakhov, V., Hainrichson, M., Chen, F., Schacht, J., Pilch, D. S., Ben-Yosef, T., & Baasov, T. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801640k · Cited by 190
Sgambati, M. T., Stolle, C., Choyke, P. L., Walther, M. M., Zbar, B., Linehan, W. M., & Glenn, G. M. (2000) · The American Journal of Human Genetics · doi:10.1086/302726 · Cited by 187
Maher, E. R., Yates, J. R., & Ferguson-Smith, M. A. (1990) · Journal of Medical Genetics · doi:10.1136/jmg.27.5.311 · Cited by 177
The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth
Schermer, B., Ghenoiu, C., Bartram, M., Müller, R. U., Kotsis, F., Höhne, M., Kühn, W., Rapka, M., Nitschke, R., Zentgraf, H., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605092 · Cited by 174
Eng, C., Crossey, P. A., Mulligan, L. M., Healey, C. S., Houghton, C., Prowse, A., Chew, S. L., Dahia, P. L., O'Riordan, J. L., & Toledo, S. P. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.934 · Cited by 172
One Ring to Rule a Superfamily of E3 Ubiquitin Ligases
Tyers, M., & Willems, A. R. (1999) · Science · doi:10.1126/science.284.5414.601 · Cited by 165
pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation
Frew, I. J., Thoma, C. R., Georgiev, S., Minola, A., Hitz, M., Montani, M., Moch, H., & Krek, W. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.96 · Cited by 162
Esteban, M. A., Harten, S. K., Tran, M. G., & Maxwell, P. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020181 · Cited by 161
Bommi‐Reddy, A., Almeciga, I., Sawyer, J., Geisen, C., Li, W., Harlow, E., Kaelin, W. G., & Grueneberg, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806574105 · Cited by 151
Surgical management of cerebellar hemangioblastomas in patients with von Hippel–Lindau disease
Jagannathan, J., Lonser, R. R., Smith, R. K., DeVroom, H. L., & Oldfield, E. H. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/108/2/0210 · Cited by 151
Genotype-phenotype correlation in von Hippel-Lindau syndrome
Friedrich, C. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.763 · Cited by 150
Bishop, T., Lau, K. W., Epstein, A. C. R., Kim, S. K., Jiang, M., O’Rourke, D., Pugh, C. W., Gleadle, J., Taylor, M. S., Hodgkin, J., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020289 · Cited by 149
Kishida, T., Stackhouse, T. M., Chen, F., Lerman, M. I., & Zbar, B. (1995) · PubMed · Cited by 148
Crossey, P. A., Foster, K., Richards, F. M., Phipps, M. E., Latif, F., Tory, K., Jones, M. H., Bentley, E., Kumar, R., Lerman, M., et al. (1994) · Human Genetics · doi:10.1007/bf00218913 · Cited by 148
Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
Dollfus, H., Massin, P., Taupin, P., Nemeth, C., Amara, S., Giraud, S., Béroud, C., Dureau, P., Gaudric, A., Landais, P., et al. (2002) · PubMed · Cited by 147
Lee, J., Dong, S. M., Park, W. S., Yoo, N. J., Kim, C. S., Jang, J., Chi, J. G., Zbar, B., Lubensky, I. A., Linehan, W. M., et al. (1998) · PubMed · Cited by 146
VHL Gene Deletion and Enhanced VEGF Gene Expression Detected in the Stromal Cells of Retinal Angioma
Chan, C. C. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.5.625 · Cited by 146
van Rooijen, E., Voest, E. E., Logister, I., Korving, J., Schwerte, T., Schulte‐Merker, S., Giles, R. H., & van Eeden, F. J. (2009) · Blood · doi:10.1182/blood-2008-07-167890 · Cited by 146
Self-citationGallou‐Kabani, C., Joly, D., JEAN, A. M., Staroz, F., Martin, N., Tarlet, G., Orfanelli, M.-T., Bouvier, R., Droz, D., tien, Y. C., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:6<464::aid-humu6>3.0.co;2-a · Cited by 144
Genetics of pheochromocytoma and paraganglioma in Spanish patients.
Cascón, A., Pita, G., Burnichon, N., Landa, I., López-Jiménez, E., Montero-Conde, C., Leskelä, S., Leandro-García, L., Letón, R., Rodríguez-Antona, C., et al. (2009) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2008-2756 · Cited by 143
Software and database for the analysis of mutations in the VHL gene
Béroud, C. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.256 · Cited by 143
Primary Cilium Formation Requires von Hippel-Lindau Gene Function in Renal-Derived Cells
Lutz, M. S., & Burk, R. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0501 · Cited by 141
Jiang, Y., Zhang, W., Kondo, K., Klco, J. M., Martin, T. B. S., Dufault, M. R., Madden, S. F., Kaelin, W. G., & Nacht, M. (2003) · PubMed · Cited by 139
Blankenship, C., Naglich, J. G., Whaley, J. M., Seizinger, B. R., & Kley, N. (1999) · Oncogene · doi:10.1038/sj.onc.1202473 · Cited by 138
Trichloroethylene Exposure and Specific Somatic Mutations in Patients With Renal Cell Carcinoma
Brauch, H. B. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.10.854 · Cited by 137
Mutations in the VHL gene in sporadic apparently congenital polycythemia
Pastore, Y. D., Jelinek, J., Ang, S., Guan, Y., Liu, E., Jedlickova, K., Krishnamurti, L., & Prchal, J. T. (2003) · Blood · doi:10.1182/blood-2002-06-1843 · Cited by 136
Maher, E. R. (2004) · Current Molecular Medicine · doi:10.2174/1566524043359827 · Cited by 131
Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.
Hatva, E., Böhling, T., Jääskeläinen, J. E., Persico, M. G., Haltia, M., & Alitalo, K. K. (1996) · Europe PMC (PubMed Central) · Cited by 128
Zhu, H., & Bunn, H. F. (2001) · Science · doi:10.1126/science.1060849 · Cited by 127
Krieg, M., Marti, H. H., & Plate, K. H. (1998) · Blood · doi:10.1182/blood.v92.9.3388 · Cited by 126
Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL
Woodward, E. R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1051 · Cited by 125
Franke, G., Bausch, B., Hoffmann, M. M., Cybulla, M., Wilhelm, C., Kohlhase, J., Scherer, G., & Neumann, H. P. H. (2009) · Human Mutation · doi:10.1002/humu.20948 · Cited by 124
Vengellur, A., WOODS, B. G., Ryan, H. E., Johnson, R. S., & LaPres, J. J. (2003) · Gene Expression · doi:10.3727/000000003108749062 · Cited by 124
Flamme, I., Krieg, M., & Plate, K. H. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65541-1 · Cited by 119
Renal cysts, renal cancer and von Hippel-Lindau disease
Neumann, H. P. H., & Zbar, B. (1997) · Kidney International · doi:10.1038/ki.1997.3 · Cited by 116
Rapid detection of VHL exon deletions using real-time quantitative PCR
Hoebeeck, J., van der Luijt, R. B., Poppe, B. G., Smet, E. D., Yigit, N., Claes, K., Zewald, R. A., de Jong, G.-J., Paepe, A. D., Speleman, F., et al. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700209 · Cited by 112
van Houwelingen, K. P., van Dijk, B. A. C., de Kaa, C. A. H., Schouten, L. J., Gorissen, H., Schalken, J. A., van den Brandt, P. A., & Oosterwijk, E. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-57 · Cited by 112
Hickey, M. M., Lam, J. C., Bezman, N. A., Rathmell, W. K., & Simon, M. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32614 · Cited by 110
Glavač, D., Neumann, H. P. H., Wittke, C., Jaenig, H., Masek, O., Streicher, T., Pausch, F., Engelhardt, D., Plate, K. H., Höfler, H., et al. (1996) · Human Genetics · doi:10.1007/s004390050206 · Cited by 110
Kurban, G., Duplan, E., Ramlal, N., Hudon, V., Sado, Y., Ninomiya, Y., & Pause, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210709 · Cited by 109
Neumann, H. P. H. (1995) · JAMA · doi:10.1001/jama.1995.03530140061033 · Cited by 107
Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia
Pastore, Y., Jedlickova, K., Guan, Y., Liu, E., Fahner, J., Hasle, H., Prchal, J. F., & Prchal, J. T. (2003) · The American Journal of Human Genetics · doi:10.1086/377108 · Cited by 106
Olschwang, S., Richard, S., Boisson, C., Giraud, S., Laurent‐Puig, P., Resche, F., & Thomas, G. D. (1998) · Human Mutation · Cited by 105
Vortmeyer, A. O., Lubensky, I. A., Fogt, F., Linehan, W. M., Khettry, U., & Zhuang, Z. (1997) · Europe PMC (PubMed Central) · Cited by 104
Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
Crossey, P. A., Eng, C., Ginalska-Malinowska, M., Lennard, T. W. J., Wheeler, D., Ponder, B. A. J., & Maher, E. R. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.11.885 · Cited by 102
Okuda, H., Hirai, S.-I., Takaki, Y., Kamada, M., Baba, M., Sakai, N., Kishida, T., Kaneko, S., Yao, M., Ohno, S., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1347 · Cited by 100
Wykoff, C. C., Sotiriou, C. P., Cockman, M. E., Ratcliffe, P. J., Maxwell, P. H., Liu, E., & Harris, A. L. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601657 · Cited by 100
Gläsker, S., Bender, B., Apel, T. W., Natt, E., Velthoven, V. V., Scheremet, R., Zentner, J., & Neumann, H. P. H. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.6.758 · Cited by 100
Maranchie, J. K., Afonso, A. M., Albert, P. S., Kalyandrug, S., Phillips, J. L., Zhou, S., Peterson, J. C., Ghadimi, Β. M., Hurley, K., Riss, J., et al. (2003) · Human Mutation · doi:10.1002/humu.10302 · Cited by 98
Webster, A. R., Richards, F. M., MacRonald, F. E., Moore, A. T., & Maher, E. R. (1998) · The American Journal of Human Genetics · doi:10.1086/302037 · Cited by 98
Perrotta, S., Nobili, B., Ferraro, M., Migliaccio, C., Borriello, A., Cucciolla, V., Martinelli, V., Rossi, F., Punzo, F., Cirillo, P., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2422 · Cited by 93
Genotype–phenotype correlations in von hippel–lindau disease
Neumann, H. P. H., & Bender, B. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00336.x · Cited by 89
Germline mutations in the vhl gene in patients presenting with phaeochromocytomas
van der Harst, E., de Krijger, R. R., Dinjens, W. N. M., Weeks, L., Bonjer, H. J., Bruining, H. A., Lamberts, S. W. J., & Koper, J. W. (1998) · International Journal of Cancer · Cited by 87
Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions
Gallou‐Kabani, C., Chauveau, D., Richard, S., Joly, D., Giraud, S., Olschwang, S., Martin, N., Saquet, C., Chrétien, Y., Méjean, A., et al. (2004) · Human Mutation · doi:10.1002/humu.20082 · Cited by 86
van Zelm, M. C., Geertsema, C., Nieuwenhuis, N., de Ridder, D., Conley, M. E., Schiff, C., Tezcan, İ., Bernatowska, E. A., Hartwig, N. G., Sanders, E. A. M., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.011 · Cited by 85
Expression of Vascular Endothelial Growth Factor in Capillary Hemangioblastoma
Morii, K., Tanaka, R., Washiyama, K., Kumanishi, T., & Kuwano, R. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1885 · Cited by 84
Li, F. P., Decker, H.-J. H., Zbar, B., Stanton, V. P., Kovacs, G., Seizinger, B. R., Aburatani, H., Sandberg, A. A., Berg, S., Hosoe, S., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-2-199301150-00005 · Cited by 82
Gläsker, S. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.5.644 · Cited by 82
Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor
Grosfeld, A., Stolze, I. P., Cockman, M. E., Pugh, C. W., Edelmann, M. J., Kessler, B. M., Bullock, A. N., Ratcliffe, P. J., & Masson, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611648200 · Cited by 81
Smoking and renal cell carcinoma.
Vecchia, C. L., Negri, E., D’Avanzo, B., et al. (1990) · PubMed · Cited by 79
Hofstra, R. M. W., Stelwagen, T., Stulp, R. P., Jong, D. D., Hulsbeek, M. M. F., Kamsteeg, E.-J., van den Berg, A., Landsvater, R. M., Vermey, A., Molenaar, W. M., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768845 · Cited by 79
Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene.
Kuzmin, I., Duh, F.-M. C., Latif, F., Geil, L., Zbar, B., & Lerman, M. I. (1995) · PubMed · Cited by 77
Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene
Hes, F. J., Zewald, R. A., Peeters, T., Sijmons, R. H., Links, T. P., Verheij, J., Matthijs, G., Legius, E., Mortier, G. R., van der Torren, K., et al. (2000) · Human Genetics · doi:10.1007/s004390000265 · Cited by 77
Hsu, T., Adereth, Y., Kose, N., & Dammai, V. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511621200 · Cited by 74
Somatic mosaicism in von Hippel-Lindau disease
Murgia, A., Martella, M., Vinanzi, C., Polli, R., Perilongo, G., & Opocher, G. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<114::aid-humu20>3.0.co;2-7 · Cited by 73
Hes, F. J., van der Luijt, R. B., Janssen, A., Zewald, R., de Jong, G., Lenders, J. W. M., Links, T., LUYTEN, G., Sijmons, R. H., Eussen, H. J., et al. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00827.x · Cited by 71
Self-citationIsolated familial pheochromocytoma as a variant of von Hippel-Lindau disease
Ritter, M. M., Frilling, A., Crossey, P. A., Höppner, W., Maher, E. R., Mulligan, L. M., Ponder, B. A. J., & Engelhardt, D. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772572 · Cited by 70
Chen, F., Slife, L., Kishida, T., Mulvihill, J. J., Tisherman, S. E., & Zbar, B. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.8.716 · Cited by 70
Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes
Bauters, C., Vantyghem, M., Leteurtre, E., Odou, M., Mouton, C., Porchet, N., Wemeau, J.-L., Proye, C., & Pigny, P. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.6.e75 · Cited by 69
Gao, J., Naglich, J. G., Laidlaw, J., Whaley, J. M., Seizinger, B. R., & Kley, N. (1995) · PubMed · Cited by 65
Forman, J., Worth, C. L., Bickerton, G. R., Eisen, T. G., & Blundell, T. L. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22419 · Cited by 64
Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
Greijer, A. E., Diemen, P. M. D., Fijneman, R. J. A., Giles, R. H., Voest, E. E., van Hinsbergh, V. W. M., & Meijer, G. A. (2008) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-008-0578-9 · Cited by 63
Self-citationCybulski, C., Krzystolik, K., Murgia, A., Górski, B., Dębniak, T., Jakubowska, A., Martella, M., Kurzawski, G., Prost, M., Kojder, I., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.7.e38 · Cited by 63
Tumor Suppression by the von Hippel-Lindau Protein Requires Phosphorylation of the Acidic Domain
Lolkema, M. P., Gervais, M. L., Snijckers, C. M. J. T., Hill, R. P., Giles, R. H., Voest, E. E., & Ohh, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503220200 · Cited by 61
Self-citationFibronectin is a hypoxia‐independent target of the tumor suppressor VHL
Bluyssen, H. A. R., Lolkema, M. P., van Beest, M., Boone, M., Snijckers, C. M. J. T., Los, M., Gebbink, M. F. B. G., Braam, B. G., Holstege, F. C. P., Giles, R. H., et al. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01392-9 · Cited by 60
Self-citationBar, M., Friedman, E., Jakobovitz-Picard, O., Leibowitz, G., Lerer, I., Abeliovich, D., & Gross, D. J. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.3251150.x · Cited by 59
Latif, F., Duh, F. M., Gnarra, J. R., et al. (1993) · PubMed · Cited by 58
Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only
Hes, F. J., McKee, S., TAPHOORN, M. J. B., Rehal, P., van der Luijt, R. B., McMahon, R., van der Smagt, J. J., Dow, D., Zewald, R. A., Whittaker, J., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.12.939 · Cited by 58
Brauch, H. B., Weirich, G., Klein, B., Rabstein, S., Bolt, H. M., & Brüning, T. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.074 · Cited by 54
Reifenberger, G., REIFENBERGER, J., Bilzer, T., Wechsler, W., & Collins, V. P. (1995) · Europe PMC (PubMed Central) · Cited by 53
Brüning, T., Weirich, G., Hornauer, M. A., Höfler, H., & Brauch, H. B. (1997) · Archives of Toxicology · doi:10.1007/s002040050394 · Cited by 53
Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene
Gross, D. J., Avishai, N., Meiner, V., Filon, D., Zbar, B., & Abeliovich, D. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550742 · Cited by 52
Approaching a New Age in Duchenne Muscular Dystrophy Treatment
Wagner, K. R. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.013 · Cited by 52
Ma, X., Yang, K., Lindblad, P., Egevad, L., & Hemminki, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204692 · Cited by 52
Yoshida, M., Ashida, S., Kondo, K., Kobayashi, K., Kanno, H., Shinohara, N., Shitara, N., Kishida, T., Kawakami, S., Baba, M., et al. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00933.x · Cited by 50
Molecular basis for polycythemia
Prchal, J. F., & Prchal, J. T. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199903000-00008 · Cited by 50
Frequent Overexpression of Vascular Endothelial Growth Factor Gene in Human Renal Cell Carcinoma.
Sato, K., Terada, K., Sugiyama, T., et al. (1994) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.173.355 · Cited by 49
VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo
Lee, C. M., Hickey, M. M., Sanford, C. A., McGuire, C., Cowey, C. L., Simon, M. C., & Rathmell, W. K. (2009) · Oncogene · doi:10.1038/onc.2009.12 · Cited by 47
Cascón, A., Escobar, B., Montero‐Conde, C., Rodríguez‐Antona, C., Ruiz‐Llorente, S., Osório, A., Mercadillo, F., Letón, R., de Campos, J. M., García‐Sagredo, J. M., et al. (2007) · Human Mutation · doi:10.1002/humu.20496 · Cited by 46
Clark, P. E., & Cookson, M. S. (2008) · Cancer · doi:10.1002/cncr.23645 · Cited by 44
HAMANO, K., Esumi, M., Igarashi, H., Chino, K., Mochida, J., ISHIDAand, H., & Okada, K. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(01)69132-8 · Cited by 43
Combined Vhlh and Pten Mutation Causes Genital Tract Cystadenoma and Squamous Metaplasia
Frew, I. J., Minola, A., Georgiev, S., Hitz, M., Moch, H., Richard, S., Vortmeyer, A. O., & Krek, W. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02132-07 · Cited by 43
Pavesi, G., Feletti, A., Berlucchi, S., Opocher, G., Martella, M., Murgia, A., & Scienza, R. (2008) · PubMed · Cited by 41
Klein, B., Weirich, G., & Brauch, H. B. (2001) · Human Genetics · doi:10.1007/s004390100500 · Cited by 41
Inga, A., Iannone, R., Monti, P., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1200952 · Cited by 41
Mutational State of von Hippel-Lindau and Adenomatous Polyposis Coli Genes in Renal Tumors
Suzuki, H., Ueda, T., Komiya, A., Okano, T., Isaka, S., Shimazaki, J., & Itô, H. (2009) · Oncology · doi:10.1159/000227697 · Cited by 39
Somatic mutations of von Hippel‐Lindau (VHL) tumor‐suppressor gene in european kidney cancers
Bailly, M., Bain, C., Favrot, M., & Öztürk, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630510 · Cited by 38
Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter
Zatyka, M., Morrissey, C., Kuzmin, I., Lerman, M. I., Latif, F., Richards, F. M., & Maher, E. R. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.7.463 · Cited by 38
Zhuang, Z., Gnarra, J. R., Dudley, C. F., Zbar, B., Linehan, W. M., & Lubensky, I. A. (1996) · PubMed · Cited by 37
Knauth, K., Cartwright, E. J. P., Freund, S. M. V., Bycroft, M., & Buchberger, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809056200 · Cited by 35
Atuk, N. O., Stolle, C. A., Owen, J. A., Carpenter, J. T., & Vance, M. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4479 · Cited by 35
Allele-specific regulation of primary cilia function by the von Hippel–Lindau tumor suppressor
Lolkema, M. P., Mans, D. A., Ulfman, L. H., Volpi, S., Voest, E. E., & Giles, R. H. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201930 · Cited by 34
Self-citationRuiz‐Llorente, S., Bravo, J., Cebrián, A., Cascón, A., Pollán, M., Tellería, D., Letón, R., Urioste, M., Rodríguez‐López, R., de Campos, J. M., et al. (2004) · Human Mutation · doi:10.1002/humu.10309 · Cited by 34
Three-decade investigation of familial pheochromocytoma. An allele of von Hippel-Lindau disease?
Tisherman, S. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.22.2550 · Cited by 34
Gijtenbeek, J. M. M., Jacobs, B., Sprenger, S. H. E., Eleveld, M. J., van Kessel, A. G., Kros, J. M., Sciot, R., Calenbergh, F. V., Wesseling, P., & Jeuken, J. W. M. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.4.0977 · Cited by 33
Sprenger, S. H. E., Gijtenbeek, J. M. M., Wesseling, P., Sciot, R., Calenbergh, F. V., Lammens, M. M. Y., & Jeuken, J. W. M. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010623119469 · Cited by 32
da Rocha, J. C. C., Silva, R. L. A., Mendonca, B. B., Marui, S., Simpson, A. J. G., & Camargo, A. A. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.3.e31 · Cited by 32
Charbotel, B., Gad, S., Caïola, D., Béroud, C., Févotte, J., Bergeret, A., Ferlicot, S., & Richard, S. (2007) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-2-13 · Cited by 32
Gallou‐Kabani, C., Longuemaux, S., Deloménie, C., Méjean, A., Martin, N., Martinet, S., Palais, G., Bouvier, R., Droz, D., Krishnamoorthy, R., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200108000-00007 · Cited by 32
Kuwai, T., Kitadai, Y., Tanaka, S., Hiyama, T., Tanimoto, K., & Chayama, K. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03196.x · Cited by 31
Weirich, G., Klein, B., Wöhl, T., Engelhardt, D., & Brauch, H. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020651 · Cited by 29
Wu, K. L., Miao, H., & Khan, S. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00096.2007 · Cited by 29
Barnabas, N., Amin, M., Pindolia, K. R., Nanavati, R., Amin, M. B., & Worsham, M. J. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10086 · Cited by 29
Cited by
VHL, the story of a tumour suppressor gene
Gossage, L., Eisen, T., & Maher, E. R. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3844 · Cited by 774
von Hippel–Lindau disease: A clinical and scientific review
Maher, E. R., Neumann, H. P., & Richard, S. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.175 · Cited by 729
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Burnichon, N., Vescovo, L., Amar, L., Libé, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr324 · Cited by 309
Rednam, S. P., Erez, A., Druker, H., Janeway, K. A., Kamihara, J., Kohlmann, W. K., Nathanson, K. L., States, L. J., Tomlinson, G. E., Villani, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0547 · Cited by 280
The SOCS box—Adapting proteins for ubiquitination and proteasomal degradation
Linossi, E. M., & Nicholson, S. E. (2012) · IUBMB Life · doi:10.1002/iub.1011 · Cited by 122
Metadata
- Authors
- Nordstrom-O'Brien, M., van der Luijt, R. B., van Rooijen, E., van den Ouweland, A. M., Majoor-Krakauer, D. F., Lolkema, M. P., van Brussel, A., Voest, E. E., & Giles, R. H.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2010
- Volume
- 31
- Issue
- 5
- Pages
- n/a-n/a
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2061329487
- Cited by
- 311
- References
- 208
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.